\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\\:\ \(1\)\
\-\ \\â\\€\\¢\\ vitals\\:\\ temp\\ 98\\.4\\ degf\\,\\ bp\\ 186\\/110\\,\\ hr\\ 136\\,\\ resps\\ 18\ \(0\)\
\-\ \\â\\€\\¢\\ general\\:\\ ao\\ x\\ 3\ \(0\)\
\-\ \\â\\€\\¢\\ heart\\:\\ regular\\,\\ but\\ tachy\\ \ \(0\)\
\-\ \\â\\€\\¢\\ lungs\\:\\ ctab\ \(0\)\
\-\ \\â\\€\\¢\\ abdomen\\:\\ soft\\,\\ non\\-tender\\,\\ normoactive\\ bs\\ x4\ \(0\)\
\-\ \\â\\€\\¢\\ ext\\:\\ varus\\ deformity\\ over\\ suspected\\ fx\\ \ \(0\)\
\-\ laboratory\\:\ \(3\)\
\-\ \\â\\€\\¢\\ wbc\\:\\ 13\\.7\\ \\(high\\)\ \(0\)\
\-\ \\â\\€\\¢\\ basic\\ metabolic\\ panel\\:\\ wnl\ \(0\)\
\-\ \\â\\€\\¢\\ cardiac\\ enzymes\\:\\ negative\ \(0\)\
\-\ \\â\\€\\¢\\ pt\\ and\\ inr\\:\\ wnl\ \(0\)\
\-\ intramedulary\\ nail\\ placed\\ in\\ both\\ femurs\\.\\ pt\\.\\ receiving\\ radiation\\ therapy\\ for\\ extensive\\ bone\\ mets\\ in\\ the\\ hips\\.\\ she\\ has\\ been\\ started\\ on\\ chemotherapy\\ to\\ reduce\\ size\\ of\\ breast\\ lesion\\ with\\ the\\ ultimate\\ goal\\ of\\ resection\\.\ \(0\)\
\-\ \\â\\€\\¢\\ right\\ hip\\ and\\ pelvis\\ radiographs\ \(0\)\
\-\ 1\\)\\ within\\ the\\ subtrochanteric\\ region\\ of\\ the\\ right\\ femur\\,\\ there\\ is\\ a\\ lucent\\ slightly\\ expansile\\ lesion\\ with\\ sclerotic\\ margins\\.\\ a\\ pathologic\\ fracture\\ is\\ evident\\ through\\ the\\ lesion\\.\ \(0\)\
\-\ 2\\)\\ proximal\\ left\\ hip\\ shows\\ a\\ lucent\\ lesion\\.\ \(0\)\
\-\ \\â\\€\\¢\\ chest\\ radiograph\ \(0\)\
\-\ 1\\)\\ there\\ \\ is\\ \\ a\\ \\ large\\ \\ mass\\ \\ in\\ \\ the\\ \\ left\\ \\ breast\\ \\ along\\ \\ with\\ \\ marked\\ \\ swelling\\ \\ in\\ \\ the\\ \\ left\\ \\ axillary\\ \\ region\\.\ \(0\)\
\-\ ct\\ chest\\ \ \(2\)\
\-\ 1\\)\\ large\\ mass\\ centered\\ in\\ the\\ patient\\'s\\ left\\ breast\\ measuring\\ approximately\\ 16\\.2\\ x\\ 11\\.1\\ cm\\ in\\ cross\\-section\\.\ \(1\)\
\-\ 2\\)\\ axillary\\ adenopathy\\ measuring\\ approximately\\ 6\\.1\\ x\\ 6\\.0\\ cm\\.\ \(0\)\
\-\ pathologic\\ fracture\\,\\ metastatic\\ disease\ \(0\)\
\-\ 1\\)\\ metatstatic\\ lesions\\,\\ breast\\ cancer\\ primary\ \(0\)\
\-\ 2\\)\\ multiple\\ myeloma\\,\\ plasmacytoma\\ in\\ breast\ \(0\)\
\-\ this\\ 64\\ y\\.o\\.\\ woman\\ slipped\\ on\\ her\\ bathroom\\ floor\\ at\\ home\\ and\\ fell\\ on\\ her\\ right\\ side\\.\\ \\ \\ she\\ reports\\ 10\\/10\\ pain\\ on\\ the\\ right\\ side\\,\\ radiating\\ down\\ her\\ right\\ lower\\ extremity\\.\\ \\ \\ pt\\.\\ denied\\ cp\\,\\ sob\\,\\ or\\ loc\\.\\ she\\ also\\ acknowledges\\ a\\ left\\ breast\\ mass\\,\\ present\\ for\\ two\\ years\\;\\ and\\,\\ a\\ significant\\ weight\\ loss\\ over\\ the\\ past\\ 4\\ months\\.\ \(0\)\
\-\ epithelial\\ malignancies\\ of\\ the\\ breast\\ are\\ the\\ most\\ common\\ form\\ of\\ non\\-skin\\ cancers\\ in\\ females\\ and\\ account\\ for\\ about\\ one\\-third\\ of\\ all\\ cancers\\ in\\ women\\.\\ it\\ is\\ second\\ only\\ to\\ lung\\ cancer\\ as\\ the\\ most\\ common\\ cause\\ of\\ death\\.\\ \ \(0\)\
\-\ risk\\ factors\\ for\\ the\\ development\\ of\\ breast\\ cancer\\ include\\ a\\ family\\ history\\ \\(including\\ brca\\ gene\\)\\,\\ nulliparity\\,\\ and\\ first\\ pregnancy\\ past\\ the\\ age\\ of\\ 35\\.\\ early\\ menarche\\ or\\ late\\ menopause\\ are\\ believed\\ to\\ slightly\\ increase\\ risk\\.\\ seventy\\-five\\ percent\\ of\\ women\\,\\ however\\,\\ have\\ no\\ known\\ identifiable\\ risk\\ factors\\.\\ \ \(0\)\
\-\ breast\\ cancer\\ screening\\ by\\ way\\ of\\ mammography\\ has\\ been\\ proven\\ to\\ decrease\\ mortality\\ \\/\\ increase\\ survival\\.\\ routine\\ annual\\ mammography\\ is\\ recommended\\ for\\ women\\ over\\ the\\ age\\ of\\ 40\\.\\ when\\ symptomatic\\,\\ a\\ diagnostic\\ breast\\ imaging\\ workup\\ must\\ ensure\\.\\ \\ the\\ presenting\\ complaint\\ \\(in\\ approximately\\ 70\\%\\ of\\ diagnostic\\ cases\\)\\ is\\ breast\\ pain\\ with\\ an\\ associated\\ lump\\.\\ back\\ or\\ bone\\ pain\\,\\ jaundice\\,\\ or\\ weight\\ loss\\ are\\ worrisome\\ systemic\\ symptoms\\ that\\ may\\ be\\ caused\\ by\\ metastatses\\,\\ but\\ are\\ rarely\\ the\\ initial\\ complaint\\.\\ \\(1\\)\ \(0\)\
\-\ infiltrating\\ ductal\\ carcinoma\\ is\\ one\\ of\\ the\\ more\\ common\\ diagnoses\\,\\ and\\ when\\ metastatic\\ disease\\ ensues\\ it\\ most\\ commonly\\ involve\\ the\\ lungs\\,\\ pleura\\,\\ liver\\,\\ and\\ brain\\.\\ infiltrating\\ lobular\\ carcinoma\\ may\\ metastatize\\ to\\ unusual\\ sites\\ such\\ as\\ the\\ bone\\ marrow\\,\\ meninges\\,\\ peritoneum\\,\\ and\\ retroperitoneal\\ structures\\,\\ such\\ as\\ the\\ ureters\\.\\ \\(2\\)\ \(0\)\
\-\ treatment\\ typically\\ consists\\ of\\ surgical\\ removal\\ of\\ the\\ breast\\ mass\\ via\\ either\\ lumpectomy\\ or\\ mastectomy\\,\\ axillary\\ sentinel\\ lymph\\ node\\ biopsy\\,\\ and\\ post\\-op\\ radiation\\/chemotherapy\\ to\\ reduce\\ risk\\ of\\ recurrence\\.\\ the\\ most\\ important\\ prognostic\\ factors\\ are\\ the\\ size\\ of\\ the\\ original\\ tumor\\ and\\ amount\\ of\\ axillary\\ lymph\\ node\\ involvement\\.\\ \\(3\\)\ \(0\)\
\-\ \\[1\\]\\:\\ giuliano\\ armando\\ e\\,\\ hurvitz\\ sara\\ a\\,\\ \\"chapter\\ 17\\.\\ breast\\ disorders\\"\\ \\(chapter\\)\\.\\ mcphee\\ sj\\,\\ papadakis\\ ma\\:\\ current\\ medical\\ diagnosis\\ \\&\\ treatment\\ 2011\\:\\ http\\:\\/\\/0\\-www\\.accessmedicine\\.com\\.carlson\\.utoledo\\.edu\\/content\\.aspx\\?aid\\=8538\\.\ \(0\)\
\-\ \\[2\\]\\:\\ phan\\ alexandria\\ t\\,\\ hennessy\\ bryan\\ t\\,\\ valero\\ vicente\\,\\ \\"chapter\\ 20\\.\\ metastatic\\ breast\\ cancer\\"\\ \\(chapter\\)\\.\\ kantarjian\\ hm\\,\\ wolff\\ ra\\,\\ koller\\ ca\\:\\ md\\ anderson\\ manual\\ of\\ medical\\ oncology\\:\\ http\\:\\/\\/0\\-www\\.accessmedicine\\.com\\.carlson\\.utoledo\\.edu\\/content\\.aspx\\?aid\\=2791693\\.\ \(0\)\
\-\ \\[3\\]\\:\\ lippman\\ marc\\ e\\,\\ \\"chapter\\ 86\\.\\ breast\\ cancer\\"\\ \\(chapter\\)\\.\\ fauci\\ as\\,\\ braunwald\\ e\\,\\ kasper\\ dl\\,\\ hauser\\ sl\\,\\ longo\\ dl\\,\\ jameson\\ jl\\,\\ loscalzo\\ j\\:\\ harrison\\'s\\ principles\\ of\\ internal\\ medicine\\,\\ 17e\\:\\ http\\:\\/\\/0\\-www\\.accessmedicine\\.com\\.carlson\\.utoledo\\.edu\\/content\\.aspx\\?aid\\=2877884\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ breast\\:\\ 0\\.0625507528537808\ \(0\)\
\-\ chapter\\:\\ 0\\.05024295058871823\ \(0\)\
\-\ \\:\\:\\ 0\\.03588174019017984\ \(0\)\
\-\ \\/\\/0\\-www\\.accessmedicine\\.com\\.carlson\\.utoledo\\.edu\\/content\\.aspx\\:\\ 0\\.034982215968121025\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.024873243676125204\ \(0\)\
\-\ axillary\\:\\ 0\\.024556249492438415\ \(0\)\
\-\ cancer\\:\\ 0\\.022294962415593374\ \(0\)\
\-\ e\\:\\ 0\\.02015019367334575\ \(0\)\
\-\ \\]\\:\\ 0\\.01774489286552704\ \(0\)\
\-\ \\[\\:\\ 0\\.017693688878082963\ \(0\)\
\-\ \\,\\:\\ 0\\.017546022765009366\ \(0\)\
\-\ dl\\:\\ 0\\.01750871387997428\ \(0\)\
\-\ women\\:\\ 0\\.016476505277200123\ \(0\)\
\-\ risk\\:\\ 0\\.016376754747931672\ \(0\)\
\-\ 1\\:\\ 0\\.016137510856823068\ \(0\)\
\-\ factors\\:\\ 0\\.015233272545817156\ \(0\)\
\-\ \\)\\:\\ 0\\.015101326817212806\ \(0\)\
\-\ cancers\\:\\ 0\\.013629515285282676\ \(0\)\
\-\ \\?\\:\\ 0\\.01323364881200201\ \(0\)\
\-\ mammography\\:\\ 0\\.013135901646181057\ \(0\)\
\-\ http\\:\\ 0\\.012840430944366174\ \(0\)\
\-\ reduce\\:\\ 0\\.012768609464027046\ \(0\)\
\-\ pt\\:\\ 0\\.012607792677114097\ \(0\)\
\-\ infiltrating\\:\\ 0\\.012278124746219208\ \(0\)\
\-\ 2\\:\\ 0\\.012170003283799908\ \(0\)\
\-\ lucent\\:\\ 0\\.0120820719098337\ \(0\)\
\-\ degf\\:\\ 0\\.01166073865604034\ \(0\)\
\-\ 186\\/110\\:\\ 0\\.01166073865604034\ \(0\)\
\-\ resps\\:\\ 0\\.01166073865604034\ \(0\)\
\-\ non\\-skin\\:\\ 0\\.01166073865604034\ \(0\)\
\-\ brca\\:\\ 0\\.01166073865604034\ \(0\)\
\-\ nulliparity\\:\\ 0\\.01166073865604034\ \(0\)\
\-\ metastatize\\:\\ 0\\.01166073865604034\ \(0\)\
\-\ radiation\\/chemotherapy\\:\\ 0\\.01166073865604034\ \(0\)\
\-\ giuliano\\:\\ 0\\.01166073865604034\ \(0\)\
\-\ armando\\:\\ 0\\.01166073865604034\ \(0\)\
\-\ hurvitz\\:\\ 0\\.01166073865604034\ \(0\)\
\-\ sara\\:\\ 0\\.01166073865604034\ \(0\)\
\-\ aid\\=8538\\:\\ 0\\.01166073865604034\ \(0\)\
\-\ phan\\:\\ 0\\.01166073865604034\ \(0\)\
\-\ alexandria\\:\\ 0\\.01166073865604034\ \(0\)\
\-\ hennessy\\:\\ 0\\.01166073865604034\ \(0\)\
\-\ bryan\\:\\ 0\\.01166073865604034\ \(0\)\
\-\ valero\\:\\ 0\\.01166073865604034\ \(0\)\
\-\ vicente\\:\\ 0\\.01166073865604034\ \(0\)\
\-\ kantarjian\\:\\ 0\\.01166073865604034\ \(0\)\
\-\ wolff\\:\\ 0\\.01166073865604034\ \(0\)\
\-\ koller\\:\\ 0\\.01166073865604034\ \(0\)\
\-\ aid\\=2791693\\:\\ 0\\.01166073865604034\ \(0\)\
\-\ lippman\\:\\ 0\\.01166073865604034\ \(0\)\
\-\ kasper\\:\\ 0\\.01166073865604034\ \(0\)\
\-\ longo\\:\\ 0\\.01166073865604034\ \(0\)\
\-\ loscalzo\\:\\ 0\\.01166073865604034\ \(0\)\
\-\ 17e\\:\\ 0\\.01166073865604034\ \(0\)\
\-\ aid\\=2877884\\:\\ 0\\.01166073865604034\ \(0\)\
\-\ wnl\\:\\ 0\\.011599739749003132\ \(0\)\
\-\ x\\:\\ 0\\.011186771172013797\ \(0\)\
\-\ 16\\.2\\:\\ 0\\.010743877306093323\ \(0\)\
\-\ acknowledges\\:\\ 0\\.010743877306093323\ \(0\)\
\-\ menopause\\:\\ 0\\.010743877306093323\ \(0\)\
\-\ metastatses\\:\\ 0\\.010743877306093323\ \(0\)\
\-\ ensues\\:\\ 0\\.010743877306093323\ \(0\)\
\-\ hm\\:\\ 0\\.010743877306093323\ \(0\)\
\-\ marc\\:\\ 0\\.010743877306093323\ \(0\)\
\-\ 86\\.\\:\\ 0\\.010743877306093323\ \(0\)\
\-\ fauci\\:\\ 0\\.010743877306093323\ \(0\)\
\-\ braunwald\\:\\ 0\\.010743877306093323\ \(0\)\
\-\ hauser\\:\\ 0\\.010743877306093323\ \(0\)\
\-\ approximately\\:\\ 0\\.010491340581569773\ \(0\)\
\-\ t\\:\\ 0\\.010464830739695306\ \(0\)\
\-\ complaint\\:\\ 0\\.010444402046325173\ \(0\)\
\-\ most\\:\\ 0\\.010438281173164423\ \(0\)\
\-\ node\\:\\ 0\\.010344559908804413\ \(0\)\
\-\ tachy\\:\\ 0\\.010207547798013741\ \(0\)\
\-\ intramedulary\\:\\ 0\\.010207547798013741\ \(0\)\
\-\ subtrochanteric\\:\\ 0\\.010207547798013741\ \(0\)\
\-\ metatstatic\\:\\ 0\\.010207547798013741\ \(0\)\
\-\ seventy\\-five\\:\\ 0\\.010207547798013741\ \(0\)\
\-\ mcphee\\:\\ 0\\.010207547798013741\ \(0\)\
\-\ papadakis\\:\\ 0\\.010207547798013741\ \(0\)\
\-\ jameson\\:\\ 0\\.010207547798013741\ \(0\)\
\-\ her\\:\\ 0\\.010196078009860854\ \(0\)\
\-\ pathologic\\:\\ 0\\.00989509155749384\ \(0\)\
\-\ 98\\.4\\:\\ 0\\.009827015956146306\ \(0\)\
\-\ bathroom\\:\\ 0\\.009827015956146306\ \(0\)\
\-\ menarche\\:\\ 0\\.009827015956146306\ \(0\)\
\-\ ao\\:\\ 0\\.009531852528482007\ \(0\)\
\-\ 13\\.7\\:\\ 0\\.009531852528482007\ \(0\)\
\-\ cross\\-section\\:\\ 0\\.009531852528482007\ \(0\)\
\-\ 35\\.\\:\\ 0\\.009531852528482007\ \(0\)\
\-\ 40\\.\\:\\ 0\\.009531852528482007\ \(0\)\
\-\ jl\\:\\ 0\\.009531852528482007\ \(0\)\
\-\ harrison\\:\\ 0\\.009531852528482007\ \(0\)\
\-\ she\\:\\ 0\\.009518992624818144\ \(0\)\
\-\ increase\\:\\ 0\\.009482565627280188\ \(0\)\
\-\ nail\\:\\ 0\\.009290686448066724\ \(0\)\
\-\ 11\\.1\\:\\ 0\\.009290686448066724\ \(0\)\
\-\ lesion\\:\\ 0\\.009209286910055315\ \(0\)\
\-\ slightly\\:\\ 0\\.00913816470438379\ \(0\)\
\-\ lymph\\:\\ 0\\.009125773568636631\ \(0\)\
\-\ 6\\.0\\:\\ 0\\.009086783432422202\ \(0\)\
\-\ sl\\:\\ 0\\.009086783432422202\ \(0\)\
\-\ principles\\:\\ 0\\.009086783432422202\ \(0\)\
\-\ measuring\\:\\ 0\\.00904062360436176\ \(0\)\
\-\ hip\\:\\ 0\\.009004953365374229\ \(0\)\
\-\ diagnostic\\:\\ 0\\.008958129087333485\ \(0\)\
\-\ 136\\:\\ 0\\.008910154606199289\ \(0\)\
\-\ ultimate\\:\\ 0\\.008910154606199289\ \(0\)\
\-\ sj\\:\\ 0\\.008910154606199289\ \(0\)\
\-\ anderson\\:\\ 0\\.008910154606199289\ \(0\)\
\-\ common\\:\\ 0\\.00887407623792221\ \(0\)\
\-\ x4\\:\\ 0\\.00875435693998714\ \(0\)\
\-\ over\\:\\ 0\\.008633502341825248\ \(0\)\
\-\ 6\\.1\\:\\ 0\\.00861499117853499\ \(0\)\
\-\ \\(\\:\\ 0\\.008599544360045959\ \(0\)\
\-\ lungs\\:\\ 0\\.008560287296244116\ \(0\)\
\-\ metastatic\\:\\ 0\\.008536148427047977\ \(0\)\
\-\ worrisome\\:\\ 0\\.008488919512127152\ \(0\)\
\-\ bone\\:\\ 0\\.008426328101031229\ \(0\)\
\-\ \\`\\`\\:\\ 0\\.008333869196951655\ \(0\)\
\-\ cp\\:\\ 0\\.008267948500667938\ \(0\)\
\-\ loc\\:\\ 0\\.008267948500667938\ \(0\)\
\-\ sentinel\\:\\ 0\\.008267948500667938\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.00817360913485017\ \(0\)\
\-\ 10\\/10\\:\\ 0\\.008169922082475184\ \(0\)\
\-\ weight\\:\\ 0\\.008103031177621336\ \(0\)\
\-\ one\\-third\\:\\ 0\\.008078661670455407\ \(0\)\
\-\ 17\\.\\:\\ 0\\.008078661670455407\ \(0\)\
\-\ 20\\.\\:\\ 0\\.00799329325625227\ \(0\)\
\-\ 3\\:\\ 0\\.0079403790742323\ \(0\)\
\-\ normoactive\\:\\ 0\\.007913101957553282\ \(0\)\
\-\ meninges\\:\\ 0\\.007913101957553282\ \(0\)\
\-\ side\\:\\ 0\\.007831869052285901\ \(0\)\
\-\ femurs\\:\\ 0\\.007765978101587378\ \(0\)\
\-\ ma\\:\\ 0\\.007765978101587378\ \(0\)\
\-\ are\\:\\ 0\\.007704192278634931\ \(0\)\
\-\ fx\\:\\ 0\\.007698129828587971\ \(0\)\
\-\ plasmacytoma\\:\\ 0\\.007698129828587971\ \(0\)\
\-\ peritoneum\\:\\ 0\\.007698129828587971\ \(0\)\
\-\ identifiable\\:\\ 0\\.007633592574395601\ \(0\)\
\-\ size\\:\\ 0\\.007579036696769236\ \(0\)\
\-\ gene\\:\\ 0\\.007572058162180135\ \(0\)\
\-\ prognostic\\:\\ 0\\.007572058162180135\ \(0\)\
\-\ manual\\:\\ 0\\.007572058162180135\ \(0\)\
\-\ varus\\:\\ 0\\.007513259534440937\ \(0\)\
\-\ lumpectomy\\:\\ 0\\.0074569637481726875\ \(0\)\
\-\ enzymes\\:\\ 0\\.00735108715072092\ \(0\)\
\-\ goal\\:\\ 0\\.00735108715072092\ \(0\)\
\-\ basic\\:\\ 0\\.007206643642830719\ \(0\)\
\-\ malignancies\\:\\ 0\\.007206643642830719\ \(0\)\
\-\ oncology\\:\\ 0\\.007206643642830719\ \(0\)\
\-\ past\\:\\ 0\\.007183067386101677\ \(0\)\
\-\ slipped\\:\\ 0\\.007161800320508389\ \(0\)\
\-\ 2011\\:\\ 0\\.007161800320508389\ \(0\)\
\-\ bs\\:\\ 0\\.007118427538996497\ \(0\)\
\-\ inr\\:\\ 0\\.007076431906305252\ \(0\)\
\-\ such\\:\\ 0\\.007067017962541937\ \(0\)\
\-\ ctab\\:\\ 0\\.006996240607606266\ \(0\)\
\-\ ureters\\:\\ 0\\.006957897304863868\ \(0\)\
\-\ medical\\:\\ 0\\.006955846031920646\ \(0\)\
\-\ ext\\:\\ 0\\.006920634240093106\ \(0\)\
\-\ epithelial\\:\\ 0\\.006884392210743748\ \(0\)\
\-\ age\\:\\ 0\\.006880715146942609\ \(0\)\
\-\ as\\:\\ 0\\.006839034422720253\ \(0\)\
\-\ pleura\\:\\ 0\\.006814757642641338\ \(0\)\
\-\ believed\\:\\ 0\\.006781268478640954\ \(0\)\
\-\ jaundice\\:\\ 0\\.006748606292674855\ \(0\)\
\-\ original\\:\\ 0\\.006748606292674855\ \(0\)\
\-\ mastectomy\\:\\ 0\\.006716731224448584\ \(0\)\
\-\ diagnoses\\:\\ 0\\.006685606227874253\ \(0\)\
\-\ panel\\:\\ 0\\.006655196812233117\ \(0\)\
\-\ hips\\:\\ 0\\.006655196812233117\ \(0\)\
\-\ centered\\:\\ 0\\.006625470812428807\ \(0\)\
\-\ way\\:\\ 0\\.006625470812428807\ \(0\)\
\-\ post\\-op\\:\\ 0\\.006625470812428807\ \(0\)\
\-\ or\\:\\ 0\\.006623827704786425\ \(0\)\
\-\ sob\\:\\ 0\\.006596398184493919\ \(0\)\
\-\ lump\\:\\ 0\\.006596398184493919\ \(0\)\
\-\ myeloma\\:\\ 0\\.006567950823090528\ \(0\)\
\-\ ensure\\:\\ 0\\.006567950823090528\ \(0\)\
\-\ loss\\:\\ 0\\.006562074530339787\ \(0\)\
\-\ receiving\\:\\ 0\\.006540102398225671\ \(0\)\
\-\ mets\\:\\ 0\\.006512828208804063\ \(0\)\
\-\ when\\:\\ 0\\.006474421263534406\ \(0\)\
\-\ proven\\:\\ 0\\.006434225800773902\ \(0\)\
\-\ carcinoma\\:\\ 0\\.006407216058243033\ \(0\)\
\-\ region\\:\\ 0\\.006385188431850033\ \(0\)\
\-\ account\\:\\ 0\\.006384304732013523\ \(0\)\
\-\ lobular\\:\\ 0\\.006384304732013523\ \(0\)\
\-\ floor\\:\\ 0\\.006360033384568819\ \(0\)\
\-\ left\\:\\ 0\\.006323447548101288\ \(0\)\
\-\ females\\:\\ 0\\.006289782292883702\ \(0\)\
\-\ mass\\:\\ 0\\.006288153475913039\ \(0\)\
\-\ temp\\:\\ 0\\.006267170608546003\ \(0\)\
\-\ consists\\:\\ 0\\.0062015661890494796\ \(0\)\
\-\ ra\\:\\ 0\\.006180401716369002\ \(0\)\
\-\ 64\\:\\ 0\\.006159570556358235\ \(0\)\
\-\ percent\\:\\ 0\\.006159570556358235\ \(0\)\
\-\ mortality\\:\\ 0\\.006159570556358235\ \(0\)\
\-\ sites\\:\\ 0\\.006159570556358235\ \(0\)\
\-\ been\\:\\ 0\\.0061502510303280186\ \(0\)\
\-\ death\\:\\ 0\\.006098975931978217\ \(0\)\
\-\ cm\\:\\ 0\\.006063375973060808\ \(0\)\
\-\ radiating\\:\\ 0\\.006060068676414337\ \(0\)\
\-\ survival\\:\\ 0\\.006060068676414337\ \(0\)\
\-\ retroperitoneal\\:\\ 0\\.006022273210218495\ \(0\)\
\-\ non\\-tender\\:\\ 0\\.005985527755050406\ \(0\)\
\-\ right\\:\\ 0\\.0059631726793016974\ \(0\)\
\-\ fracture\\:\\ 0\\.005960514101250737\ \(0\)\
\-\ late\\:\\ 0\\.005881045729496662\ \(0\)\
\-\ workup\\:\\ 0\\.005815711397050132\ \(0\)\
\-\ annual\\:\\ 0\\.0056652366809698965\ \(0\)\
\-\ metabolic\\:\\ 0\\.005582537796073953\ \(0\)\
\-\ \\/\\:\\ 0\\.005582537796073953\ \(0\)\
\-\ md\\:\\ 0\\.005582537796073953\ \(0\)\
\-\ in\\:\\ 0\\.005574037435717658\ \(0\)\
\-\ expansile\\:\\ 0\\.005543049749579664\ \(0\)\
\-\ hr\\:\\ 0\\.005504706446837268\ \(0\)\
\-\ denied\\:\\ 0\\.005504706446837268\ \(0\)\
\-\ unusual\\:\\ 0\\.005467443382066506\ \(0\)\
\-\ 70\\:\\ 0\\.005431201352717148\ \(0\)\
\-\ rarely\\:\\ 0\\.005419338032634131\ \(0\)\
\-\ chest\\:\\ 0\\.005409335978988144\ \(0\)\
\-\ vitals\\:\\ 0\\.005407580165680102\ \(0\)\
\-\ fell\\:\\ 0\\.005407580165680102\ \(0\)\
\-\ systemic\\:\\ 0\\.005407580165680102\ \(0\)\
\-\ disorders\\:\\ 0\\.005407580165680102\ \(0\)\
\-\ home\\:\\ 0\\.005372920942936684\ \(0\)\
\-\ medicine\\:\\ 0\\.005361566784614738\ \(0\)\
\-\ ductal\\:\\ 0\\.005328077620614355\ \(0\)\
\-\ involve\\:\\ 0\\.005328077620614355\ \(0\)\
\-\ current\\:\\ 0\\.005295415434648254\ \(0\)\
\-\ form\\:\\ 0\\.0052847048391024614\ \(0\)\
\-\ ca\\:\\ 0\\.0052635403664219845\ \(0\)\
\-\ regular\\:\\ 0\\.00521206494810231\ \(0\)\
\-\ is\\:\\ 0\\.0052063960961548665\ \(0\)\
\-\ evident\\:\\ 0\\.005172279954402207\ \(0\)\
\-\ decrease\\:\\ 0\\.005172279954402207\ \(0\)\
\-\ must\\:\\ 0\\.005152827378489912\ \(0\)\
\-\ margins\\:\\ 0\\.005133656733909796\ \(0\)\
\-\ j\\:\\ 0\\.005105411860271478\ \(0\)\
\-\ it\\:\\ 0\\.005081609482891578\ \(0\)\
\-\ important\\:\\ 0\\.005077757515272385\ \(0\)\
\-\ sclerotic\\:\\ 0\\.005059637350777462\ \(0\)\
\-\ started\\:\\ 0\\.00504176206087439\ \(0\)\
\-\ adenopathy\\:\\ 0\\.0050329141929500555\ \(0\)\
\-\ \\'s\\:\\ 0\\.0049842503131403305\ \(0\)\
\-\ marrow\\:\\ 0\\.004972582828860039\ \(0\)\
\-\ may\\:\\ 0\\.0049585406584606445\ \(0\)\
\-\ large\\:\\ 0\\.004943233946643068\ \(0\)\
\-\ recurrence\\:\\ 0\\.004931113873986924\ \(0\)\
\-\ development\\:\\ 0\\.004922973840158381\ \(0\)\
\-\ either\\:\\ 0\\.004922973840158381\ \(0\)\
\-\ bp\\:\\ 0\\.0049068425265422185\ \(0\)\
\-\ 18\\:\\ 0\\.0049068425265422185\ \(0\)\
\-\ femur\\:\\ 0\\.0048830085245545485\ \(0\)\
\-\ deformity\\:\\ 0\\.004867354480047931\ \(0\)\
\-\ suspected\\:\\ 0\\.004867354480047931\ \(0\)\
\-\ pregnancy\\:\\ 0\\.004859596385534177\ \(0\)\
\-\ down\\:\\ 0\\.004851883527980218\ \(0\)\
\-\ via\\:\\ 0\\.004851883527980218\ \(0\)\
\-\ for\\:\\ 0\\.004822143840229597\ \(0\)\
\-\ screening\\:\\ 0\\.0048214741123390826\ \(0\)\
\-\ but\\:\\ 0\\.004821437304321528\ \(0\)\
\-\ general\\:\\ 0\\.004762675484599884\ \(0\)\
\-\ the\\:\\ 0\\.0047546050294897755\ \(0\)\
\-\ caused\\:\\ 0\\.004741282813640094\ \(0\)\
\-\ a\\:\\ 0\\.004721426212126205\ \(0\)\
\-\ amount\\:\\ 0\\.004720230624082026\ \(0\)\
\-\ recommended\\:\\ 0\\.004685871515083004\ \(0\)\
\-\ family\\:\\ 0\\.00463268841921258\ \(0\)\
\-\ presenting\\:\\ 0\\.004606877818387737\ \(0\)\
\-\ treatment\\:\\ 0\\.004575706242330389\ \(0\)\
\-\ placed\\:\\ 0\\.004575307075786356\ \(0\)\
\-\ reports\\:\\ 0\\.00455672010031592\ \(0\)\
\-\ routine\\:\\ 0\\.004532336897023806\ \(0\)\
\-\ extensive\\:\\ 0\\.00452031180218088\ \(0\)\
\-\ symptomatic\\:\\ 0\\.004490718815733085\ \(0\)\
\-\ removal\\:\\ 0\\.004456059592989666\ \(0\)\
\-\ marked\\:\\ 0\\.0044112162706673366\ \(0\)\
\-\ about\\:\\ 0\\.004357218923418322\ \(0\)\
\-\ structures\\:\\ 0\\.00435193847200359\ \(0\)\
\-\ second\\:\\ 0\\.004341440390527748\ \(0\)\
\-\ cardiac\\:\\ 0\\.004305339673215569\ \(0\)\
\-\ commonly\\:\\ 0\\.004265253232084182\ \(0\)\
\-\ has\\:\\ 0\\.0042452380171806295\ \(0\)\
\-\ laboratory\\:\\ 0\\.004165465259066224\ \(0\)\
\-\ involvement\\:\\ 0\\.004142776000830445\ \(0\)\
\-\ pain\\:\\ 0\\.00414130225210609\ \(0\)\
\-\ extremity\\:\\ 0\\.004133808160902695\ \(0\)\
\-\ early\\:\\ 0\\.004133808160902695\ \(0\)\
\-\ wbc\\:\\ 0\\.004120469379068534\ \(0\)\
\-\ pelvis\\:\\ 0\\.004107263765332842\ \(0\)\
\-\ including\\:\\ 0\\.004081241588614978\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.004051515588810668\ \(0\)\
\-\ biopsy\\:\\ 0\\.00401017624555127\ \(0\)\
\-\ typically\\:\\ 0\\.003989981176595201\ \(0\)\
\-\ \\&\\:\\ 0\\.003970089804419883\ \(0\)\
\-\ heart\\:\\ 0\\.003927354032948114\ \(0\)\
\-\ liver\\:\\ 0\\.003897118400572386\ \(0\)\
\-\ on\\:\\ 0\\.003830111176536656\ \(0\)\
\-\ cause\\:\\ 0\\.0038244214636930767\ \(0\)\
\-\ first\\:\\ 0\\.0037929675063304922\ \(0\)\
\-\ internal\\:\\ 0\\.003789518348384618\ \(0\)\
\-\ swelling\\:\\ 0\\.0037656228359538788\ \(0\)\
\-\ cases\\:\\ 0\\.0037656228359538788\ \(0\)\
\-\ by\\:\\ 0\\.003764208738743055\ \(0\)\
\-\ initial\\:\\ 0\\.00374547902550173\ \(0\)\
\-\ along\\:\\ 0\\.0037355210011356032\ \(0\)\
\-\ back\\:\\ 0\\.003728923724004599\ \(0\)\
\-\ radiation\\:\\ 0\\.00370932704968563\ \(0\)\
\-\ disease\\:\\ 0\\.0036950728603590056\ \(0\)\
\-\ radiograph\\:\\ 0\\.0036004611824356648\ \(0\)\
\-\ radiographs\\:\\ 0\\.003579723334923456\ \(0\)\
\-\ known\\:\\ 0\\.003576787148761666\ \(0\)\
\-\ resection\\:\\ 0\\.0035250207083600774\ \(0\)\
\-\ brain\\:\\ 0\\.003401258628707357\ \(0\)\
\-\ only\\:\\ 0\\.0033986926699536182\ \(0\)\
\-\ proximal\\:\\ 0\\.0033935756371785914\ \(0\)\
\-\ to\\:\\ 0\\.003389429432087192\ \(0\)\
\-\ negative\\:\\ 0\\.003375820319278934\ \(0\)\
\-\ there\\:\\ 0\\.0033643268689549964\ \(0\)\
\-\ abdomen\\:\\ 0\\.0033483918821371646\ \(0\)\
\-\ primary\\:\\ 0\\.0033483918821371646\ \(0\)\
\-\ years\\:\\ 0\\.003319104678595876\ \(0\)\
\-\ lung\\:\\ 0\\.0032740200003158015\ \(0\)\
\-\ y\\.o\\:\\ 0\\.003262406656860714\ \(0\)\
\-\ two\\:\\ 0\\.003237210631767203\ \(0\)\
\-\ of\\:\\ 0\\.0032362166888330116\ \(0\)\
\-\ through\\:\\ 0\\.0032102606063768102\ \(0\)\
\-\ all\\:\\ 0\\.0031969887426339825\ \(0\)\
\-\ include\\:\\ 0\\.0031708379471300087\ \(0\)\
\-\ 4\\:\\ 0\\.003149433737009319\ \(0\)\
\-\ however\\:\\ 0\\.0031473122428532676\ \(0\)\
\-\ shows\\:\\ 0\\.0031076371689535433\ \(0\)\
\-\ high\\:\\ 0\\.0030933148956042533\ \(0\)\
\-\ months\\:\\ 0\\.0030872239347752213\ \(0\)\
\-\ one\\:\\ 0\\.0030631367504109046\ \(0\)\
\-\ significant\\:\\ 0\\.0030394803585373324\ \(0\)\
\-\ lesions\\:\\ 0\\.0030258736856401424\ \(0\)\
\-\ therapy\\:\\ 0\\.003022011635238906\ \(0\)\
\-\ both\\:\\ 0\\.002886507924187991\ \(0\)\
\-\ more\\:\\ 0\\.002826952790095458\ \(0\)\
\-\ symptoms\\:\\ 0\\.002817007244574258\ \(0\)\
\-\ physical\\:\\ 0\\.002773155118493701\ \(0\)\
\-\ soft\\:\\ 0\\.002752548629621098\ \(0\)\
\-\ \\;\\:\\ 0\\.0026791285561542245\ \(0\)\
\-\ associated\\:\\ 0\\.0026672785210419335\ \(0\)\
\-\ imaging\\:\\ 0\\.002648245799544448\ \(0\)\
\-\ \\%\\:\\ 0\\.002636668033526465\ \(0\)\
\-\ tumor\\:\\ 0\\.0026352279121836125\ \(0\)\
\-\ and\\:\\ 0\\.002619178654833866\ \(0\)\
\-\ woman\\:\\ 0\\.0026109827347736854\ \(0\)\
\-\ diagnosis\\:\\ 0\\.0025955282153180157\ \(0\)\
\-\ present\\:\\ 0\\.002552921632184763\ \(0\)\
\-\ lower\\:\\ 0\\.0025421455943966434\ \(0\)\
\-\ exam\\:\\ 0\\.0024831136771819285\ \(0\)\
\-\ have\\:\\ 0\\.002447669415826841\ \(0\)\
\-\ multiple\\:\\ 0\\.0023806957717979744\ \(0\)\
\-\ surgical\\:\\ 0\\.002375954722554833\ \(0\)\
\-\ also\\:\\ 0\\.0022283327958599886\ \(0\)\
\-\ within\\:\\ 0\\.002156258476701166\ \(0\)\
\-\ that\\:\\ 0\\.0019523554610566445\ \(0\)\
\-\ be\\:\\ 0\\.0017430644488676311\ \(0\)\
\-\ \\.\\:\\ 0\\.0015965399832139858\ \(0\)\
\-\ ct\\:\\ 0\\.0015810894886138134\ \(0\)\
\-\ an\\:\\ 0\\.0015630487622813887\ \(0\)\
\-\ history\\:\\ 0\\.0015611303408823855\ \(0\)\
\-\ at\\:\\ 0\\.0015314327418407842\ \(0\)\
\-\ this\\:\\ 0\\.0012713455202567896\ \(0\)\
\-\ no\\:\\ 0\\.0011381536384970925\ \(0\)\
\-\ patient\\:\\ 0\\.0011330581096777618\ \(0\)\
\-\ with\\:\\ 0\\.0006190697147613213\ \(0\)\
